Bläker H - Search Results

1

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial.

Sinn M, Riess H, Sinn BV, Stieler JM, Pelzer U, Striefler JK, Oettle H, Bahra M, Denkert C, Bläker H, Lohneis P. Sinn M, et al. Among authors: blaker h. Eur J Cancer. 2015 Aug;51(12):1546-54. doi: 10.1016/j.ejca.2015.05.005. Epub 2015 Jun 3. Eur J Cancer. 2015. PMID: 26049689 Clinical Trial.

2

Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.

Dietel M, Jöhrens K, Laffert M, Hummel M, Bläker H, Müller BM, Lehmann A, Denkert C, Heppner FL, Koch A, Sers C, Anagnostopoulos I. Dietel M, et al. Among authors: blaker h. Cancer Gene Ther. 2013 Apr;20(4):211-21. doi: 10.1038/cgt.2013.13. Epub 2013 Mar 15. Cancer Gene Ther. 2013. PMID: 23492822 Review.

3

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study.

Sinn M, Sinn BV, Striefler JK, Lindner JL, Stieler JM, Lohneis P, Bischoff S, Bläker H, Pelzer U, Bahra M, Dietel M, Dörken B, Oettle H, Riess H, Denkert C. Sinn M, et al. Among authors: blaker h. Ann Oncol. 2014 May;25(5):1025-32. doi: 10.1093/annonc/mdu084. Epub 2014 Feb 20. Ann Oncol. 2014. PMID: 24562449 Free article. Clinical Trial.

4

Lymph node count and prognosis in colorectal cancer: the influence of examination quality.

Bläker H, Hildebrandt B, Riess H, von Winterfeld M, Ingold-Heppner B, Roth W, Kloor M, Schirmacher P, Dietel M, Tao S, Jansen L, Chang-Claude J, Ulrich A, Brenner H, Hoffmeister M. Bläker H, et al. Int J Cancer. 2015 Apr 15;136(8):1957-66. doi: 10.1002/ijc.29221. Epub 2014 Sep 24. Int J Cancer. 2015. PMID: 25231924

5

Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition.

von Winterfeld M, Hoffmeister M, Ingold-Heppner B, Jansen L, Tao S, Herpel E, Schirmacher P, Dietel M, Chang-Claude J, Autschbach F, Brenner H, Bläker H. von Winterfeld M, et al. Among authors: blaker h. Eur J Cancer. 2014 Nov;50(17):2958-65. doi: 10.1016/j.ejca.2014.09.002. Epub 2014 Sep 30. Eur J Cancer. 2014. PMID: 25281526

6

Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.

Walter TC, Steffen IG, Stelter LH, Maurer MH, Bahra M, Faber W, Klein F, Bläker H, Hamm B, Denecke T, Grieser C. Walter TC, et al. Among authors: blaker h. Eur Radiol. 2015 May;25(5):1329-38. doi: 10.1007/s00330-014-3520-3. Epub 2014 Nov 30. Eur Radiol. 2015. PMID: 25433414 Free article.

7

Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.

Arnold A, Bahra M, Lenze D, Bradtmöller M, Guse K, Gehlhaar C, Bläker H, Heppner FL, Koch A. Arnold A, et al. Among authors: blaker h. Exp Mol Pathol. 2015 Oct;99(2):344-53. doi: 10.1016/j.yexmp.2015.08.003. Epub 2015 Aug 8. Exp Mol Pathol. 2015. PMID: 26260902

8

A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.

Dietel M, Jöhrens K, Laffert MV, Hummel M, Bläker H, Pfitzner BM, Lehmann A, Denkert C, Darb-Esfahani S, Lenze D, Heppner FL, Koch A, Sers C, Klauschen F, Anagnostopoulos I. Dietel M, et al. Among authors: blaker h. Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11. Cancer Gene Ther. 2015. PMID: 26358176 Review.

9

CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma: A Case Report and Review of the Literature.

Rotzinger R, Bläker H, Bahra M, Denecke T, Grieser C. Rotzinger R, et al. Among authors: blaker h. J Investig Med High Impact Case Rep. 2015 Mar 16;3(1):2324709615576988. doi: 10.1177/2324709615576988. eCollection 2015 Jan-Mar. J Investig Med High Impact Case Rep. 2015. PMID: 26425636 Free PMC article.

10

P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment.

Striefler JK, Sinn M, Pelzer U, Jühling A, Wislocka L, Bahra M, Sinn BV, Denkert C, Dörken B, Oettle H, Riess H, Bläker H, Lohneis P. Striefler JK, et al. Among authors: blaker h. Pathol Res Pract. 2016 Aug;212(8):726-34. doi: 10.1016/j.prp.2016.06.001. Epub 2016 Jun 8. Pathol Res Pract. 2016. PMID: 27461834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters